Chimeric antigen receptors: unleashing a new age of anti-cancer therapy

Background Chimeric antigen receptors (CARs) represent a novel facet of modern day synthetic biology that exemplifies personalized medicine at work through their ability to harness and redirect a patient’s immune system to fight cancer.